These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

829 related articles for article (PubMed ID: 25037990)

  • 1. Effectiveness of maternal pertussis vaccination in England: an observational study.
    Amirthalingam G; Andrews N; Campbell H; Ribeiro S; Kara E; Donegan K; Fry NK; Miller E; Ramsay M
    Lancet; 2014 Oct; 384(9953):1521-8. PubMed ID: 25037990
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pertussis vaccination in infancy lowers the incidence of pertussis disease and the rate of hospitalisation after one and two doses: analyses of 10 years of pertussis surveillance.
    Nilsson L; Lepp T; von Segebaden K; Hallander H; Gustafsson L
    Vaccine; 2012 May; 30(21):3239-47. PubMed ID: 22094282
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hospitalisation of preterm infants with pertussis in the context of a maternal vaccination programme in England.
    Byrne L; Campbell H; Andrews N; Ribeiro S; Amirthalingam G
    Arch Dis Child; 2018 Mar; 103(3):224-229. PubMed ID: 28814424
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A case-control study to assess the effectiveness of pertussis vaccination during pregnancy on newborns, Valencian community, Spain, 1 March 2015 to 29 February 2016.
    Bellido-Blasco J; Guiral-Rodrigo S; Míguez-Santiyán A; Salazar-Cifre A; González-Morán F
    Euro Surveill; 2017 Jun; 22(22):. PubMed ID: 28598324
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A case-control study to estimate the effectiveness of maternal pertussis vaccination in protecting newborn infants in England and Wales, 2012-2013.
    Dabrera G; Amirthalingam G; Andrews N; Campbell H; Ribeiro S; Kara E; Fry NK; Ramsay M
    Clin Infect Dis; 2015 Feb; 60(3):333-7. PubMed ID: 25332078
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost-effectiveness and programmatic benefits of maternal vaccination against pertussis in England.
    van Hoek AJ; Campbell H; Amirthalingam G; Andrews N; Miller E
    J Infect; 2016 Jul; 73(1):28-37. PubMed ID: 27108802
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Experience and challenges on influenza and pertussis vaccination in pregnant women.
    Madhi SA; Nunes MC
    Hum Vaccin Immunother; 2018; 14(9):2183-2188. PubMed ID: 30024822
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is adding maternal vaccination to prevent whooping cough cost-effective in Australia?
    Van Bellinghen LA; Dimitroff A; Haberl M; Li X; Manton A; Moeremans K; Demarteau N
    Hum Vaccin Immunother; 2018; 14(9):2263-2273. PubMed ID: 29771574
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unexpectedly limited durability of immunity following acellular pertussis vaccination in preadolescents in a North American outbreak.
    Witt MA; Katz PH; Witt DJ
    Clin Infect Dis; 2012 Jun; 54(12):1730-5. PubMed ID: 22423127
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trends in Canadian infant pertussis hospitalizations in the pre- and post-acellular vaccine era, 1981-2016.
    Desai S; Schanzer DL; Silva A; Rotondo J; Squires SG
    Vaccine; 2018 Nov; 36(49):7568-7573. PubMed ID: 30392765
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effectiveness of maternal pertussis vaccination in preventing infection and disease in infants: The NSW Public Health Network case-control study.
    Saul N; Wang K; Bag S; Baldwin H; Alexander K; Chandra M; Thomas J; Quinn H; Sheppeard V; Conaty S
    Vaccine; 2018 Mar; 36(14):1887-1892. PubMed ID: 29501321
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Whooping cough, twenty years from acellular vaccines introduction.
    Greco D; Esposito S; Tozzi A; Pandolfi E; Icardi G; Giammanco A
    Ann Ig; 2015; 27(2):415-31. PubMed ID: 26051141
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Whole-cell and acellular pertussis vaccination programs and rates of pertussis among infants and young children.
    Vickers D; Ross AG; Mainar-Jaime RC; Neudorf C; Shah S
    CMAJ; 2006 Nov; 175(10):1213-7. PubMed ID: 17098950
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effectiveness of acellular pertussis vaccine assessed by hospital-based active surveillance in Germany.
    Juretzko P; von Kries R; Hermann M; Wirsing von König CH; Weil J; Giani G
    Clin Infect Dis; 2002 Jul; 35(2):162-7. PubMed ID: 12087522
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Underestimating the safety benefits of a new vaccine: the impact of acellular pertussis vaccine versus whole-cell pertussis vaccine on health services utilization.
    Hawken S; Manuel DG; Deeks SL; Kwong JC; Crowcroft NS; Wilson K
    Am J Epidemiol; 2012 Dec; 176(11):1035-42. PubMed ID: 23118103
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of changing from whole-cell to acellular pertussis vaccine on the epidemiology of hospitalized children with pertussis in Canada.
    Bettinger JA; Halperin SA; De Serres G; Scheifele DW; Tam T
    Pediatr Infect Dis J; 2007 Jan; 26(1):31-5. PubMed ID: 17195702
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term follow-up of Swedish children vaccinated with acellular pertussis vaccines at 3, 5, and 12 months of age indicates the need for a booster dose at 5 to 7 years of age.
    Gustafsson L; Hessel L; Storsaeter J; Olin P
    Pediatrics; 2006 Sep; 118(3):978-84. PubMed ID: 16950988
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Experience with monocomponent acellular pertussis combination vaccines for infants, children, adolescents and adults--a review of safety, immunogenicity, efficacy and effectiveness studies and 15 years of field experience.
    Thierry-Carstensen B; Dalby T; Stevner MA; Robbins JB; Schneerson R; Trollfors B
    Vaccine; 2013 Oct; 31(45):5178-91. PubMed ID: 23994021
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pertussis in infants under one year old: risk markers and vaccination status--a case-control study.
    Zamir CS; Dahan DB; Shoob H
    Vaccine; 2015 Apr; 33(17):2073-8. PubMed ID: 25728322
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pertussis in the Netherlands, is the current vaccination strategy sufficient to reduce disease burden in young infants?
    van der Maas NA; Mooi FR; de Greeff SC; Berbers GA; Spaendonck MA; de Melker HE
    Vaccine; 2013 Sep; 31(41):4541-7. PubMed ID: 23933365
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 42.